Skip to main content
Preston Campbell III, MD, Pediatric Pulmonology, Bethesda, MD

PrestonWhiteCampbellIIIMD

Pediatric Pulmonology • Bethesda, MD

EVP Medical Affairs CF Foundation

Join to view full profile

Dr. Campbell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Campbell's full profile

Already have an account?

  • Office

    6931 Arlington Rd
    Bethesda, MD 20814
    Phone+1 301-907-2689

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Pediatric Pulmonology, 1990 - 1993
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Pediatrics, 1980 - 1983
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1980

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1998 - 2022
  • TN State Medical License
    TN State Medical License 1982 - 1999
  • Pediatrics
    American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Press Mentions

  • New Drug Appears to Slow Effects of Cystic Fibrosis, Offering Hope to Long-Suffering Patients
    New Drug Appears to Slow Effects of Cystic Fibrosis, Offering Hope to Long-Suffering PatientsDecember 18th, 2019
  • Cystic Fibrosis Foundation Statement on FDA Approval of TRIKAFTA, the First Triple-Combination Therapy for the Most Common CF Mutation
    Cystic Fibrosis Foundation Statement on FDA Approval of TRIKAFTA, the First Triple-Combination Therapy for the Most Common CF MutationNovember 7th, 2019
  • Preston W. Campbell, President and CEO of the Cystic Fibrosis Foundation to Retire; Michael P. Boyle, MD, Appointed as Successor Effective January 2020
    Preston W. Campbell, President and CEO of the Cystic Fibrosis Foundation to Retire; Michael P. Boyle, MD, Appointed as Successor Effective January 2020May 21st, 2019

Dr. Preston Campbell, Dr. Preston Campbell, MD, Dr. P Campbell, Dr. Preston White Campbell